SWAN’s NIH Renewal Focuses on Women’s Later-Life Health

On 23 September 2026, the University of Pittsburgh announced that the Study of Women’s Health Across the Nation (SWAN) and its seven research sites received $44,456,682 in NIH support over five years. Pittsburgh coordinates the study, which follows women across menopause and into later life.

The Healthspan Question

The central healthy-aging question is how patterns recorded around menopause relate to physical and cognitive functioning decades later. According to the University of Pittsburgh and UCLA Health, the renewed funding supports investigation of cognitive function and overall well-being alongside bone and cardiovascular health. The emphasis is on understanding later-life health and the ability to remain independent. SWAN’s contribution to this question comes from connecting a long midlife record with assessments of participants as they grow older.

Human Follow-Up

Study model: Humans, followed over time in an observational longitudinal cohort.

According to UCLA Health’s 5 October 2026 announcement, SWAN has followed participants since 1995, when they were in their mid-40s. Pittsburgh describes a diverse, multi-ethnic group followed for more than 30 years. Participants are now in their 70s. That history gives the renewed program a substantial record of women’s experiences before its next round of assessments.

The study’s timeline is central to its purpose. Researchers are following the same participants through different stages of life rather than looking only at their current health. The useful question is how earlier observations relate to later outcomes. This connects menopause research with questions about functioning and well-being that become increasingly relevant as the cohort ages.

The research network also spans several institutions. Pittsburgh’s announcement lists the University of Pittsburgh and Massachusetts General Hospital alongside the University of Michigan and UC Davis/Kaiser Permanente. It also lists UCLA, Albert Einstein College of Medicine and Rush University Medical Center. The renewal supports this shared program rather than describing a separate award of the stated total to each institution.

Metabolism in Context

UCLA Health identifies body composition, glucose metabolism and cardiovascular risk factors among the areas where SWAN has contributed to understanding menopause-related changes. These topics place metabolic aging within the study’s broader account of women’s health. The announcement also highlights work on bone strength and menopause symptoms. It connects that history with later-life health risks including osteoporosis and dementia.

For readers interested in metabolism, the important feature is this connection across health domains. The announced research places metabolic observations beside cardiovascular health and physical functioning. A useful future analysis would explain which earlier measurements relate to which later outcomes. That would make the connection between midlife research and healthy aging more specific than a general statement about menopause and metabolism.

UCLA investigator Arun Karlamangla described the participants’ experience across menopause and beyond as providing information about “bio-psycho-social changes in midlife” and their implications for aging. His description brings biological observations together with psychological and social experience. It is a broad research frame, consistent with the program’s attention to overall well-being as well as individual health measures.

This breadth makes careful outcome definitions especially valuable. Body composition and glucose metabolism are different subjects of measurement, even when both appear within the same research program. Reading each result according to its stated outcome helps keep the wider story coherent. A useful background framework is how researchers assess and validate aging biomarkers.

Function and Independence

Karlamangla said the next phase will assess participants’ physical and cognitive functioning. He described the goal as adding understanding that could help develop guidelines for healthy aging and preserving independence later in life. That places everyday functioning near the center of the program’s ambitions. The research aims to connect the earlier record with how participants are doing now.

Maria Mori Brooks, principal investigator of the SWAN coordinating center, similarly emphasized the relationship between midlife health and later ability to carry out daily activities. She described the work as collaborative across clinical and scientific disciplines. Her comments explain why the study reaches beyond an isolated metabolic measurement. The announced questions concern the links between earlier health and later functioning.

SWAN principal investigator Rebecca Thurston highlighted another part of that rationale. She said continued follow-up can help researchers understand how menopause relates to long-term heart, brain and bone health. Together, these investigator descriptions give the renewal a clear direction. The program is bringing its midlife history forward into research on several aspects of later-life health.

For a research-minded reader, this is the most useful organizing frame: identify the earlier exposure or measurement, then identify the later outcome being studied. Physical functioning and cognitive functioning each deserve their own interpretation. Cardiovascular and bone assessments add further perspectives. Keeping those questions separate makes it easier to understand how individual publications contribute to the larger program.

New Assessments

The University of Pittsburgh says the new phase will add neuroimaging to SWAN for the first time. Its announcement also describes hormone testing and physical-function testing. Spine X-rays will examine bone density and microfractures. These planned assessments expand the information available for investigating the cohort’s later-life health.

Adding neuroimaging gives the program another way to investigate its brain-health questions. The editorial significance is the connection between a new type of assessment and an existing history of participants’ midlife health. Researchers can formulate questions that bring those records together. The eventual publications will show how the new imaging information is used within specific analyses.

The distinction between blood-based measures and brain imaging is relevant when following this expanded work. Different assessments contribute different kinds of information. The clearest reports will identify the measure being analyzed and the health question it addresses. That approach helps readers follow the research without treating the full collection of tests as a single result.

Bone assessments fit the same larger strategy. Pittsburgh specifically describes spine X-rays for examining bone density and microfractures. These measurements sit alongside the announced physical-function assessments and the program’s interest in independence. Together, the planned work gives researchers several routes for investigating the relationship between midlife history and later-life health.

Evidence Boundaries

• The announcement reports funding and aims, not new results. Neither university announcement presents findings from the newly funded period. The investigators describe questions they intend to investigate and knowledge they hope to gain. Read the renewal as support for continued research, not as evidence that a treatment works or that the new phase has already produced clinical guidance.
• Long follow-up does not establish cause by itself. SWAN is observational. Interpreting relationships between menopause and later health requires attention to chronological aging and other influences. When future analyses appear, look for how they address alternative explanations before treating an observed relationship as evidence that menopause caused a particular outcome.
• A diverse cohort still needs a detailed description. The public award announcement does not provide the baseline sample size or a detailed racial and ethnic breakdown. It also does not give a full account of enrollment criteria. Future findings should be read alongside the population actually analyzed rather than assumed to represent every woman’s experience of menopause.
• Prior contributions are described broadly. UCLA Health names body composition and glucose metabolism among SWAN’s research areas, but this announcement is not a detailed metabolic results paper. It does not supply a specific new finding for each topic it lists. Readers evaluating a claim about one metabolic marker should seek the corresponding analysis and its reported measurements.
• The assessment schedule matters. Pittsburgh lists planned tests but does not provide the visit schedule in the public announcement. Understanding a future result will require knowing when its measurements were taken and how they fit the participant’s earlier record. Use the methods in the eventual publication to interpret the timeline rather than inferring it from the funding summary.
• Function and longevity are distinct outcomes. The announced program emphasizes later-life health, physical and cognitive functioning, and independence. Those are meaningful healthy-aging questions. They should be judged on their own terms rather than treated as evidence that the funding or the planned assessments will extend participants’ lives.

The Next Milestone

The next milestone is publication of analyses that connect SWAN’s midlife records with its new later-life assessments, using clearly defined outcomes and methods that address age and other competing explanations.

How AgeAmaze helps

An aging study’s funding total can overshadow the unanswered questions, a problem AgeAmaze addresses by keeping research findings and their uncertainty in focus. Its research-led coverage helps skeptical adults navigate conflicting longevity studies through readable explanations of healthy aging and biological mechanisms, giving readers a grounded basis for judging emerging work.

Read the research

Sources

1. SWAN receives $44M from NIH to understand the impact of aging on women
2. SWAN Receives More Than $44M From NIH to Understand the Impact of Aging on Women